Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-19

Clinical Trial Update: Bioavailability and Effectiveness of Transdermally Administered Morphine [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the bioavailability and preliminary effectiveness of a transdermal morphine formulation for cancer-related pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (transdermal) (morphine)

Snippet

Sponsor: Alberta Health services | Conditions: Cancer, Pain | Phase 1 | Status: COMPLETED